5-Bromoveratraldehyde - CAS 6948-30-7
Catalog: |
BB033843 |
Product Name: |
5-Bromoveratraldehyde |
CAS: |
6948-30-7 |
Synonyms: |
3-bromo-4,5-dimethoxybenzaldehyde |
IUPAC Name: | 3-bromo-4,5-dimethoxybenzaldehyde |
Description: | 5-Bromoveratraldehyde (CAS# 6948-30-7) is used as a reagent to synthesize aromatic vinyl sulfones, compounds that act as inhibitors of HIV-1. 3-Bromo-4,5-dimethoxybenzaldehyde is used as a reagent to synthesize (-)-Tejedine, a secobisbenzylisoquinoline compound that naturally occurs in Barberry (a medicinal plant). |
Molecular Weight: | 245.07 |
Molecular Formula: | C9H9BrO3 |
Canonical SMILES: | COC1=C(C(=CC(=C1)C=O)Br)OC |
InChI: | InChI=1S/C9H9BrO3/c1-12-8-4-6(5-11)3-7(10)9(8)13-2/h3-5H,1-2H3 |
InChI Key: | ICVODPFGWCUVJC-UHFFFAOYSA-N |
Boiling Point: | 313.8 °C at 760 mmHg |
Density: | 1.482 g/cm3 |
MDL: | MFCD00003346 |
LogP: | 2.27880 |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
CN-113045578-A | Novel total synthesis method of racemic tetrandrine | 20210318 |
WO-2020032080-A1 | Compound, salt of compound, neuromodulation agent, method for evaluating neuromodulation agent, method for producing compound, and method for producing salt of compound | 20180807 |
JP-WO2020032080-A1 | Compounds, compounds' salts, neurological function regulators, methods for evaluating neurological function regulators, methods for producing compounds, and methods for producing compounds' salts. | 20180807 |
WO-2019129121-A1 | Derivatives of phenylmethanone as fto inhibitors | 20171228 |
CN-111902386-A | Phenyl methanone derivatives as FTO inhibitors | 20171228 |
PMID | Publication Date | Title | Journal |
16826970 | 20060601 | Synthesis and anxiolytic activity of 1-phenyl-2-(4-aryl-1,3,4,5-tetrahydropyrido[2,3-b][1 ,4]diazepin-2-ylidene)-ethanone | Die Pharmazie |
Complexity: | 174 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 243.97351 |
Formal Charge: | 0 |
Heavy Atom Count: | 13 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 243.97351 |
Rotatable Bond Count: | 3 |
Topological Polar Surface Area: | 35.5 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 2 |
-
Catalog: BB030404
(-)-Citronellal
Detail
-
Catalog: BB010000
(+)-3-Bromocamphor-8-sulfonic Acid Ammonium Salt
Detail
-
Catalog: BB033577
(-)-2,3:4,6-Di-O-isopropylidene-2-keto-L-gulonic Acid Monohydrate
Detail
-
Catalog: BB010056
(±)-cis-Cyclopentane-1,2-dicarboxylic acid
Detail
-
Catalog: BB021353
(+)-O,O'-Di-p-toluoyl-D-tartaric Acid
Detail
-
Catalog: BB032683
(-)-Dipivaloyl-L-tartaric Acid
Detail
-
Catalog: BB015442
(±)-8a-Methyl-3,4,8,8a-tetrahydro-1,6(2H,7H)-naphthalenedione
Detail
-
Catalog: BB036558
(+)-O,O'-Dibenzoyl-D-tartaric Acid Monohydrate
Detail
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Carbonyl Compounds
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS